Literature DB >> 12997667

Radiotherapy in breast cancer. I. The dose-time relationship theoretical considerations.

L COHEN.   

Abstract

Entities:  

Keywords:  BREAST/neoplasms

Mesh：

Year:  1952        PMID： 12997667     DOI： 10.1259/0007-1285-25-300-636

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  6 in total

1.  Assessment of contralateral mammary gland dose in the treatment of breast cancer using accelerated hypofractionated radiotherapy.

Authors:  Maria Tolia; Kalliopi Platoni; Andreas Foteineas; Maria-Aggeliki Kalogeridi; Anna Zygogianni; Nikolaos Tsoukalas; Mariangela Caimi; Niki Margari; Maria Dilvoi; Panagiotis Pantelakos; John Kouvaris; Vassilis Kouloulias
Journal:  World J Radiol       Date:  2011-09-28

2.  Integrating genomic information and signaling dynamics for efficient cancer therapy.

Authors:  Jacob Stewart-Ornstein; Galit Lahav
Journal:  Curr Opin Syst Biol       Date:  2016-12-19

3.  The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

Authors:  S M Bentzen; R K Agrawal; E G A Aird; J M Barrett; P J Barrett-Lee; J M Bliss; J Brown; J A Dewar; H J Dobbs; J S Haviland; P J Hoskin; P Hopwood; P A Lawton; B J Magee; J Mills; D A L Morgan; J R Owen; S Simmons; G Sumo; M A Sydenham; K Venables; J R Yarnold
Journal:  Lancet Oncol       Date:  2008-03-19       Impact factor: 41.316

4.  Changes in radiotherapy fractionation-breast cancer.

Authors:  John Yarnold
Journal:  Br J Radiol       Date:  2018-03-19       Impact factor: 3.039

5.  Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)-study protocol for a multicentre, randomized phase III trial.

Authors:  Sanjoy Chatterjee; Santam Chakraborty
Journal:  Trials       Date:  2020-09-30       Impact factor: 2.279

6.  Treatment completion rates and toxicity of 5 fractions of adjuvant radiotherapy over one week in elderly breast cancer patients treated with lumpectomy.

Authors:  Álvaro Flores Sánchez; Jorge Contreras Martínez; Remedios Priego Ortiz
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.